Pharmatek Launches New API Manufacturing Program
Pharmatek develops two new cGMP manufacturing suites for API-in-capsule productions.
Pharmatek, a contract development and manufacturing organization, has launched a new API-in-capsule manufacturing program. The program is designed to address manufacturing strategies that will lower development cost, shorten timelines, and increase capsule throughput for API-in-capsule productions.
As part of the program, Pharmatek has developed two new cGMP manufacturing suites designed specifically for API-in-capsule productions. The suites include humidity control and inert gas systems, which contribute to a stronger manufacturing process for API-in-capsule productions. In addition, Pharmatek has implemented operational systems to further address efficiencies, including new project teams, updated batch records, extended shift operations, redundant equipment and change parts, and on-demand inventory management.
Source: Pharmatek
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
